Identifying the Cellular Mechanisms Leading to Heterotopic Ossification

Calcified Tissue International

Volumn 97, Issue 5, 2015, Pages 432-444

  Davies, O G ^a   Grover, L M ^b   Eisenstein, N ^b   Lewis, M P ^a,c   Liu, Y ^a  

^a LOUGHBOROUGH UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^c Nottingham Biomedical Research Centre   (United Kingdom)

Author keywords

Chondrogenic; Endothelium; Epithelium; Mesenchyme; Myoblast; Ossification; Osteogenic; Pericyte; Stem cell

Indexed keywords

BIOLOGICAL MARKER; PALOVAROTENE; RETINOIC ACID DERIVATIVE; RETINOIC ACID RECEPTOR GAMMA; RETINOIC ACID RECEPTOR GAMMA AGONIST; UNCLASSIFIED DRUG;

CELL POPULATION; CELLS BY BODY ANATOMY; CHONDROGENESIS; DIAGNOSTIC IMAGING; ECTODERM; ENCHONDRAL OSSIFICATION; ENDOTHELIUM CELL; EPITHELIUM CELL; GENETIC DISORDER; HETEROTOPIC OSSIFICATION; HUMAN; INFLAMMATION; INJURY; MESENCHYMAL STEM CELL; MYOBLAST; NEURAL CREST; NONHUMAN; OSSIFICATION; OSSIFYING MYOSITIS; PATHOGENESIS; PERICYTE; PHENOTYPE; PRIORITY JOURNAL; RAMAN SPECTROMETRY; REVIEW; SATELLITE CELL; METABOLISM; PATHOPHYSIOLOGY;

HUMANS; OSSIFICATION, HETEROTOPIC;

EID: 84943626745     PISSN: 0171967X     EISSN: 14320827     Source Type: Journal    
DOI: 10.1007/s00223-015-0034-1     Document Type: Review

References (110)

1. Kan L, Kessler JA (2011) Animal models of typical heterotopic ossification. J Biomed Biotechnol. doi:10.1155/2011/309287
2. Kaplan FS, Shore EM (2000) Perspective: progressive osseous heteroplasia. JBMR 15(11):2084–2094
3. Atzeni F, Sarzi-Puttini P, Bevilacqua M (2006) Calcium deposition and associated chronic diseases (atherosclerosis, diffuse idiopathic skeletal hyperostosis, and others). Rheum Dis Clin North Am 32(2):413–426
4. Potter BK, Burns TC, Lacap AP (2007) Heterotopic ossification following traumatic and combat-related amputations. Prevalence, risk factors, and preliminary results of excision. J Bone Joint Surg Am 89(3):476–486
5. Alfieri KA, Forsberg JA, Potter BK (2012) Blast injuries and heterotopic ossification. Bone Joint Res 1(8):192–197
6. Potter BK, Burns TC, Lacap AP et al (2006) Heterotopic ossification in the residual limbs of traumatic and combat-related amputees. J Am Acad Orthop Surg 14(10):191–197
7. Forsberg JA, Pepek JM, Wagner S et al (2009) Heterotopic ossification in high-energy wartime extremity injuries: prevalence and risk factors. J Bone Joint Surg Am 91:1084–1091
8. Genet F, Jourdan C, Lautridou C et al (2011) The impact of preoperative hip heterotopic ossification extent on recurrence in patients with head and spinal cord injury: a case control study. PLoS ONE 6(8):e23129
9. Potter BK, Forsberg JA, Davis TA et al (2010) Heterotopic ossification following combat-related trauma. J Bone Joint Surg Am 92(2):74–89
10. Wick L, Berger M, Knecht H et al (2005) Magnetic resonance signal alterations in the acute onset of heterotopic ossification in patients with spinal cord injury. Eur Radiol 15:1867–1875
11. Beckmann JT, Wylie JD, Kapron AL et al (2014) The effect of NSAID prophylaxis and operative variables on heterotopic ossification after hip arthroplasty. Am J Sports Med 42:1359–1364
12. Burd T, Hughes M, Anglen J (2003) Heterotopic ossification prophylaxis with indomethacin increases the risk of long-bone non-union. J Bone Joint Surg Br 85:700–705
13. Moed BR, Resnick RB, Fakhouri AJ et al (1994) Effect of two nonsteroidal anti-inflammatory drugs on heterotopic bone formation in a rabbit model. J Arthroplast 9:81–87
14. Cella JP, Salvati EA, Sculco TP et al (1988) Indomethacin for the prevention of heterotopic ossification following total hip arthroplasty. Effectiveness, contraindications, and adverse effects. J Arthroplast 3:229–234
15. Healy WL, Lo TC, Covall DJ et al (1990) Single-dose radiation therapy for prevention of heterotopic ossification after total hip arthroplasty. J Arthroplast 5(4):369–375
16. Strauss JB, Wysocki RW, Shah A et al (2011) Radiation therapy for heterotopic ossification prophylaxis after high-risk elbow surgery. Am J Orthop 40(8):400–405
17. Popovic M, Agarwal A, Zhang L et al (2014) Radiotherapy for the prophylaxis of heterotopic ossification: a systematic review and meta-analysis of published data. Radiother Oncol 113:10–17
18. Pakos EE, Pitouli EJ, Tsekeris PG et al (2006) Prevention of heterotopic ossification in high-risk patients with total hip arthroplasty: the experience of a combined therapeutic protocol. Int Orthop 30:79–83
19. Kim JH, Chu FC, Woodard HQ et al (1978) Radiation-induced soft tissue and bone sarcoma. Radiology 129:501–508
20. Mazonakis M, Berris T, Lyraraki E et al (2013) Cancer risk estimates from radiation therapy for heterotopic ossification prophylaxis after total hip arthroplasty. Med Phys 40(10):101702
21. Haran M, Bhuta T, Lee B (2004) Pharmacological interventions for treating acute heterotopic ossification. Cochrane Database Syst Rev 4. CD003321
22. Prabhu RK, Swaminathan N, Harvey LA (2013) Passive movements for the treatment and prevention of contractures. Cochrane Database Syst Rev. doi:10.1002/14651858
23. Kurer MH, Khoker MA, Dandona P (1992) Human osteoblast stimulation by sera from paraplegic patients with heterotopic ossification. Paraplegia 30:165–168
24. McCarthy EF, Sundaram M (2005) Heterotopic ossification: a review. Skeletal Radiol 34(10):609–619
25. Kim KS, Heo DH (2013) Do postoperative biomechanical changes induce heterotopic ossification after cervical ossification after cervical arthroplasty? A 5-year follow-up study. J Spinal Disord Tech. doi:10.1097/BSD.0000000000000054
26. Evans KN, Forsberg JA, Potter BK et al (2012) Inflammatory cytokine and chemokine expression is associated with heterotopic ossification in high-energy penetrating war injuries. J Orthop Trauma 26(11):e204–e213
27. Friedenstein AJ, Chailakhyan RK, Gerasimov UV (1987) Bone marrow osteogenic stem cells: in vitro cultivation and transplantation in diffusion chambers. Cell Tissue Kinet 20(3):263–272
28. Scotti C, Tonnarelli B, Papadimitropoulos A et al (2010) Recapitulation of endochondral bone formation using human adult mesenchymal stem cells as a paradigm for developmental engineering. Proc Natl Acad Sci USA 107(16):7251–7256
29. Sasaki J, Matsumoto T, Egusa H et al (2012) In vitro reproduction of endothelial ossification using a 3D mesenchymal stem cell construct. Integr Biol (Camb) 4(10):1207–1214
30. Farrell E, Both SK, Odorfer KI et al (2011) In vivo generation of bone via endochondral ossification by in vitro chondrogenic priming of adult human and rat mesenchymal stem cells. BMC Musculoskelet Disord 12:31
31. Chen J, Li Y, Wang L et al (2001) Terapeutic benefit of intravenous administration of bone marrow stromal cells after cerebral ischemia in rats. Stroke 32(4):1005–1011
32. Brazelton TR, Nystrom M, Blau HM (2003) Significant differences among skeletal muscles in the incorporation of bone marrow-derived cells. Dev Biol 262(1):64–74
33. Nesti LJ, Jackson WM, Shanti RM et al (2008) Differentiation potential of multipotent progenitor cells derived from war-traumatized muscle tissue. J Bone Joint Surg Am 90:2390–2398
34. Jackson WM, Aragon AB, Bulken-Hoover JD et al (2009) Putative heterotopic ossification progenitor cells derived from traumatized muscle. J Orthop Res 27(12):1645–1651
35. Davis TA, Lazdun Y, Potter BK et al (2013) Ectopic bone formation in severely combat-injured orthopedic patients: a hematopoietic niche. Bone 56:119–126
36. Simonsen LL, Sonne-Holm S, Krasheninnikoff M (2007) Symptomatic heterotopic ossification after very severe traumatic brain injury in 114 patients: incidence and risk factors. Injury 38(10):1146–1150
37. Peterson JR, De La Rosa S, Eboda O et al (2014) Burn injury enhances bone formation in heterotopic ossification model. Ann Surg 259(5):993–998
38. Ayala-Lugo A, Tavares AM, Paz AH et al (2011) Age-dependent availability and functionality of bone marrow stem cells in an experimental model of acute and chronic myocardial infarction. Cell Transplant 20(3):407–419
39. Asumda FZ, Chase PB (2011) Age-related changes in rat bone-marrow mesenchymal stem cell plasticity. BMC Cell Biol 12:44
40. Efimenko A, Dzhoyashvil N, Kalinina N et al (2014) Adipose-derived mesenchymal stromal cells from aged patients with coronary artery disease keep mesenchymal stromal cell properties but exhibit characteristics of aging and have impaired angiogenic potential. Stem Cells Transl Med 3(1):32–41
41. Liu L, Gao J, Yuan Y et al (2013) Hypoxia preconditioned human adipose derived mesenchymal stem cells enhance angiogenic potential via secretion of increased VEGF and bFGF. Cell Biol Int 37(6):551–560
42. Olmsted-Davis E, Gannon FH, Ozen M et al (2007) Hypoxic adipocytes pattern early heterotopic bone formation. Am J Pathol 170(2):620–632
43. Dilling CF, Wada AM, Lazard ZW et al (2010) Vessel formation is induced prior to the appearance of cartilage in BMP-2 mediated heterotopic ossification. J Bone Miner Res 25(5):1147–1156
44. Shi M, Liu ZW, Wang FS (2011) Immunomodulatory properties and therapeutic application of mesenchymal stem cells. Clin Exp Immunol 164(1):1–8
45. Niedbala W, Cai B, Liew FY (2006) Role of nitric oxide in the regulation of T cell functions. Ann Rheum Dis 65:37–40
46. Veis A, Sires B, Clohisy J (1989) A search for the osteogenic factor in dentin. Rat incisor dentin contains a factor stimulating rat muscle cells in vitro to incorporate sulphate into an altered proteoglycan. Connect Tissue Res 23(2–3):137–144
47. Bosch P, Musgrave DS, Lee JY et al (2000) Osteoprogenitor cells within skeletal muscle. J Orthop Res 18(6):933–944
48. Gao X, Usas A, Tang Y et al (2014) A comparison of bone regeneration with human mesenchymal stem cells and muscle-derived stem cells and the critical role of BMP. Biomaterials 35(25):6859–6870
49. Katagiri T, Yamaguchi A, Komaki M et al (1994) Bone morphogenetic protein-2 converts the differentiation pathway of C2C12 myoblasts into the osteoblast lineage. Cell Biol 128(4):1755–1766
50. Nakashima K, Zhou X, Kunkel G et al (2002) The novel zinc finger-containing transcription factor Osterix is required for osteoblast differentiation and bone formation. Cell 108:17–29
51. Dugan JM, Cartmell SH, Gough JE (2014) Uniaxial cyclic strain of human adipose-derived mesenchymal stem cells and C2C12 myoblasts in coculture. J Tissue Eng. doi:10.1177/2041731414530138
52. Mu X, Li Y (2010) Conditional TGF-β1 treatment increases stem cell-like cell population in myoblasts. J Cell Mol Med 15(3):679–690
53. Suutre S, Toom A, Arend A et al (2009) Bone tissue content of TGF-beta2 changes with time in human heterotopic ossification after total hip arthroplasty. Growth Factors 27(2):114–120
54. Peault B, Rudnicki M, Torrente Y et al (2007) Stem and progenitor cells in skeletal muscle development, maintenance, and therapy. Mol Ther 15(5):867–877
55. Liu R, Peacock L, Mikulec K et al (2012) The role of MyoD+ muscle in progenitor cells in bone formation and repair. J Bone Joint Surg Br 94-B:131
56. Lounev VY, Ramachandran R, Wosczyna MN et al (2009) Identification of progenitor cells that contribute to heterotopic skeletogenesis. J Bone Joint Surg Am 91:652–663
57. Asakura A, Komaki M, Rudnicki M (2001) Muscle satellite cells are multipotential stem cells that exhibit myogenic, osteogenic, and adipogenic differentiation. Differentiation 68(4–5):245–253
58. Wada MR, Inagawa-Ogashiwa M, Shimizu S et al (2002) Generation of different fates from multipotent muscle stem cells. Development 129(12):2987–2995
59. Bosch P, Musgrave DS, Lee JY et al (2005) Osteoprogenitor cells within skeletal muscle. J Orthop Res 18(6):933–944
60. Hashimoto N, Kiyono T, Wada MR et al (2008) Osteogenic properties of human myogenic progenitor cells. Mech Dev 125(3–4):257–269
61. Wu X, Walters TJ, Rathbone CR (2013) Skeletal muscle satellite cell activation following cutaneous burn in rats. Burns 39(4):736–744
62. Uezumi A, Fukada S, Yamamoto N (2010) Mesenchymal progenitors distinct from satellite cells contribute to ectopic fat cell formation in skeletal muscle. Nat Cell Biol 12:143–152
63. Uezumi A, Ito T, Morikawa D et al (2011) Fibrosis and adipogenesis originate from a common mesenchymal progenitor in skeletal muscle. J Cell Sci 124:3654–3664
64. LaBarge MA, Blau HM (2002) Biological progression from adult bone marrow to mononucleate muscle stem cell to multinucleate muscle fibre in response to injury. Cell 111:589–601
65. Starkey JD, Yamamoto M, Yamamoto S et al (2011) Skeletal muscle satellite cells are committed to myogenesis and do not spontaneously adopt nonmyogenic fates. J Histochem Cytochem 59(1):33–46
66. Mitchell KJ, Pannerec A, Cadot B et al (2010) Identification and characterization of non-satellite cell muscle resident progenitor during postnatal development. Nat Cell Biol 12(3):257–266
67. Lamanga C, Bergers G (2006) The bone marrow constitutes a reservoir of pericyte progenitors. J Leukoc Biol 80(4):677–681
68. Motohashi N, Uezumi A, Yada E et al (2008) Muscle CD31(-) CD45(-) side population cells promote muscle regeneration by stimulating proliferation and migration of myoblasts. Am J Pathol 173(3):781–791
69. Uezumi A, Ojima K, Fukada S et al (2006) Functional heterogeneity of side population cells in skeletal muscle. Biochem Biophys Res Commun 341:864–873
70. McKinney-Freeman SL, Jackson KA, Camargo FD et al (2002) Muscle-derived hematopoietic stem cells are hematopoietic in origin. Proc Natl Acad Sci USA 99(3):1341–1346
71. Olmsted-Davis EA, Gugala Z, Camargo Z et al (2003) Primitive adult hematopoietic stem cells can function as osteoblast precursors. Proc Natl Acad Sci USA 100(26):15877–15882
72. Chan CK, Chen CC, Luppen CA et al (2009) Endochondral ossification is required for haematopoietic stem-cell niche formation. Nature 457(7228):490–494
73. Otsuru S, Tamai K, Yamazaki T et al (2008) Circulating bone marrow-derived osteoblast progenitor cells are recruited to the bone-forming site by the CXCR4/stromal cell-derived factor-1 pathway. Stem Cells 26(1):223–234
74. Wlodarski K (1978) Failure of heterotopic osteogenesis by epithelial mesenchymal cell interactions in xenogenic transplants in the kidney. Calcif Tissue Res 25(1):7–11
75. Mattioli M, Gloria A, Turriani M et al (2012) Osteo-regenerative potential of ovarian granulosa cells: an in vitro and in vivo study. Theriogenology 77(7):1425–1437
76. Huggins CB (1930) Experimental osteogenesis. Proc Soc Exper Biol Med 27:349–351
77. Maroulakou IG, Shibat MA, Anver M et al (1999) Heterotopic endochondral ossification with mixed tumor formation in C3(1)/Tag transgenic mice is associated with elevated TGF-beta1 and BMP-2 expression. Oncogene 18(39):5435–5447
78. Wang Q, Wu W, Han X et al (2014) Osteogenic differentiation of amniotic epithelial cells: synergism of pulsed electromagnetic field and biochemical stimuli. BMC Musculoskelet Disord 15:271
79. Tsai MT, Li WJ, Tuan RS et al (2009) Modulation of osteogenesis in human mesenchymal stem cells by specific pulsed electromagnetic field stimulation. J Orthop Res 27(9):1169–1174
80. Rutherford RB, Racenis P, Fatherazi S et al (2003) Bone formation by BMP-7 transduced human gingival keratinocytes. J Dent Res 82(4):293–297
81. Bittner K, Vischer P, Bartholmes P et al (1998) Role of the subchondral vascular system in endochondral ossification: endothelial cells specifically derepress late differentiation in resting chondrocytes in vitro. Exp Cell Res 238(2):491–497
82. Chen V, Yang JY, Chuang SS et al (2009) Heterotopic ossification in burns: our experiences and literature reviews. Burns 35:857–862
83. Alini M, Marriott A, Chen T et al (1996) A novel angiogenic molecule produced at the time of chondrocyte hypertrophy during endochondral bone formation. Dev Biol 176(1):124–132
84. Carlevaro MF, Albini A, Ribatti D et al (1997) Transferrin promotes endothelial cell migration and invasion: implication in cartilage neovascularization. J Cell Biol 136:1375–1384
85. Kim S, Lee JC, Cho ES (2013) COMP-Ang1 promotes chondrogenic and osteogenic differentiation of multipotent mesenchymal stem cells through the Ang1/Tie2 signalling pathway. J Orthop Res 31(12):1920–1928
86. Jeong BC, Kim HJ, Bae IH et al (2010) COMP-Ang1, a chimeric form of Angiopoietin 1, enhances BMP2-induced osteoblast differentiation and bone formation. Bone 46(2):479–486
87. Kusumbe AP, Ramasamy SK, Adams RH (2014) Coupling of angiogenesis and osteogenesis by specific vessel subtype in bone. Nature 507(7492):323–328
88. Lamouille S, Xu J, Derynck R (2014) Molecular mechanisms of epithelial-mesenchymal transition. Nat Rev Mol Cell Biol 15(3):178–196
89. Medici D, Shore EM, Lounev VY et al (2010) Conversion of vascular endothelial cells into multipotent stem-like cells. Nat Med 16(12):1400–1406
90. Downey J, Lauzier D, Kloen P et al (2015) Prospective heterotopic ossification progenitors in adult human skeletal muscle. Bone 71:164–170
91. Tran KV, Gealekman O, Frontini A et al (2012) The vascular endothelium of the adipose tissue gives rise to both white and brown fat cells. Cell Metab 15(2):222–229
92. Shore EM, Kaplan FS (2010) Inherited human diseases of heterotopic bone formation. Nat Rev Rheumatol 6(9):518–527
93. Diaz-Flores L, Gutierrez R, Valladares F et al (1992) Pericytes as a supplementary source of osteoblasts in periosteal osteogenesis. Clin Orthop Relat Res 275:280–286
94. Woscyzna MN, Biswas AA, Cogswell CA et al (2012) Multipotent progenitors resident in the skeletal muscle interstitium exhibit robust BMP-dependent osteogenic activity and mediate heterotopic ossification. J Bone Miner Res 27(5):1004–1017
95. Houlihan DD, Mabuchi Y, Morikawa S et al (2012) Isolation of mouse mesenchymal stem cells on the basis of expression of Sca-1 and PDGFRα. Nat Protoc 7(12):2103–2111
96. Crisan M, Corselli M, Chen CW et al (2011) Multilineage stem cells in the adult: a perivascular legacy? Organogenesis 7(2):581–589
97. Doherty MJ, Ashton BA, Walsh S et al (1998) Vascular pericytes express osteogenic potential in vitro and in vivo. J Bone Miner Res 13(5):828–838
98. Kirton JP, Crofts NJ, George SJ et al (2007) Wnt/beta-catenin signalling stimulates chondrogenic and inhibits adipogenic differentiation of pericytes: potential relevance to vascular disease. Circ Res 101(6):581–589
99. Goritz C, Dias DO, Tomilin N et al (2011) A pericyte origin of spinal cord scar tissue. Science 333:238–242
100. Armulik A, Genove G, Betsholtz C (2011) Pericytes: developmental, physiological, and pathological perspectives, problems, and promises. Dev Cell 21(2):193–215
101. Kinner B, Zaleskas JM, Spector M (2002) Regulation of smooth muscle actin expression and contraction in adult human mesenchymal stem cells. Exp Cell Res 278(1):72–83
102. Song L, Young NJ, Webb NE et al (2005) Origin and characterization of multipotential mesenchymal stem cells derived from adult human trabecular bone. Stem Cells Dev 14:712–721
103. Rajantie I, IImonen M, Alminaite A et al (2004) Adult bone marrow-derived cells recruited during angiogenesis comprise precursors for periendothelial vascular mural cells. Blood 104(7):2084–2086
104. De Palma M, Venneri MA, Galli R et al (2005) Tie2 identifies a hematopoietic lineage of proangiogenic monocytes required for tumor vessel formation and a mesenchymal population of pericyte progenitors. Cancer Cell 8(3):211–226
105. Evans NK, Potter BK, Brown TS et al (2014) Osteogenic gene expression correlates with development of heterotopic ossification in war wounds. Clin Orthop Relat Res 472:396–404
106. Peterson JR, Okagbare PI, De La Rosa S et al (2013) Early detection of burn induced heterotopic ossification using transcutaneous Raman spectroscopy. Bone 54:28–34
107. Perosky JE, Peterson JR, Eboda ON et al (2014) Early detection of heterotopic ossification using near-infrared optical imaging reveals dynamic turnover and progression of mineralisation following Achilles tenotomy and burn injury. J Orthop Res 32(11):1416–1423
108. Shimono K, Tung WE, Macolino C et al (2011) Potent inhibition of heterotopic ossification by nuclear retinoic acid receptor-[gamma] agonists. Nat Med 17:454–460
109. Johnson RW, Sims NA (2014) Embedded in bone, but looking beyond: osteocalcin, epigenetics and ectopic bone formation (ASBMR 2014). IBMS BoneKEy 11
110. Zimmermann SM, Wurgler-Hauri CC, Wanner GA et al (2013) Echinomycin in the prevention of heterotopic ossification—an experimental antibiotic agent shows promising results in a murine model. Injury 44:570–575